First-line management of metastatic non-small cell lung cancer: An Indian perspective

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: First-line management of metastatic non-small cell lung cancer: An Indian perspective ; volume:08 ; number:02 ; year:2019 ; pages:073-079
South Asian journal of cancer ; 08, Heft 02 (2019), 073-079

Contributor: Ghadyalpatil, Nikhil Suresh
Pandey, Avinash
Krishnamani, Iyer
Srinivas, Chilukuri
Rafiq, Shabnam J.
Hingmire, Sachin S.
Maturu, Nagarjuna
Reddy, Ragotham
Kumar, Kiran K.
Sreekanth, K.
Gurram, Bharath Chandra
Parikh, P. M.

DOI: 10.4103/sajc.sajc_294_18

URN: urn:nbn:de:101:1-2021021720135718224838

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ghadyalpatil, Nikhil Suresh
Pandey, Avinash
Krishnamani, Iyer
Srinivas, Chilukuri
Rafiq, Shabnam J.
Hingmire, Sachin S.
Maturu, Nagarjuna
Reddy, Ragotham
Kumar, Kiran K.
Sreekanth, K.
Gurram, Bharath Chandra
Parikh, P. M.

Other Objects (12)

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

AIH Therapy: Beyond First-Line

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

AIH Therapy: Beyond First-Line

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

AIH Therapy: Beyond First-Line

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

First-line management of metastatic non-small cell lung cancer: An Indian perspective

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

AIH Therapy: Beyond First-Line

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

AIH Therapy: Beyond First-Line

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

AIH Therapy: Beyond First-Line

Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer

First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology

First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

Related objects

Reset password